&nbsp;

Apr 2023

Drug

EPIrubicin

Other Name(s): Pharmorubicin PFS®

Quick Link(s):

Apr 2023

Drug

vanDETanib

Other Name(s): Caprelsa®

Quick Link(s):

Aug 2023

Drug

vemURAFenib

Other Name(s): Zelboraf ®

Quick Link(s):

Aug 2023

Drug

vismodegib

Other Name(s): Erivedge®

Quick Link(s):

Oct 2023

Regimen

ECARBOF

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Neoadjuvant, Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

ECX

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

ECX

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Adjuvant, Neoadjuvant

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

ECF

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

EVER

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

Exceptional Access Program

Drugs Used:

everolimus

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

VAND

Cancer Type:

Endocrine,

Thyroid

Intent: Palliative

Funding:

Exceptional Access Program

vanDETanib - Monotherapy for symptomatic and/or progressive medullary thyroid cancer (MTC), with specific criteria

Drugs Used:

vanDETanib

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

VEMU

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

Exceptional Access Program

vemURAFenib - Monotherapy in patients with BRAF V600 mutation-positive unresectable stage Ill or stage IV melanoma, with specific criteria

Drugs Used:

vemURAFenib

... Show more tags